pillbase.ru

Trogarzo

Active substance: ibalizumab

Ibalizumab

Centralised EU authorisationWithdrawn

Marketing holder: Theratechnologies Europe Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • TROGARZO
    INJECTION, SOLUTION · IBALIZUMAB 150 mg/mL
    62064-122
    Theratechnologies Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12092-13cb-76e2-a09c-7c3d05892b7d;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004961
Registration status
Withdrawn
ATC code
J05AX
Sources
  • product · EMA · EMEA/H/C/004961 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004961 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004961 · Verified 2026-10-09